Mayo Clinic Study Confirms MBI High Absolute Sensitivity for Supplemental, Low-Dose Screening Studies in Women with Dense Breast Tissue

January 27, 2015

study conducted by Mayo Clinic and published in the AJR has clinically confirmed that Molecular Breast Imaging (MBI) yields superior imaging and low radiation exposure for women with dense breast tissue, which can affect up to 40 percent of the female population. 

In the study, the LumaGEM MBI System demonstrated a reduction in radiation dose from 20 mCi to 8 mCi, a dose reduction not achievable with older-generation scintillating gamma cameras, known as scintimammography or breast-specific gamma imaging(BSGI) systems.

Read the full story.